The generation and regulation of functional diversity of malignant plasma cells.
Cellular diversity, which is a hallmark of malignancy, can be generated by both genetic and nongenetic mechanisms. We describe here variability in the adhesive and migratory behavior of malignant plasma cell populations, including multiple myeloma-derived lines and primary patient samples. Examination of the plasma cell lines ARH-77, CAG, and AKR revealed two distinct subpopulations of cells, one displaying highly adhesive properties (type A) and the other consisting of poorly adhesive, floating cells (type F). In the ARH-77 cell line, type A cells attach better to fibronectin and to human bone fragments and form paxillin-rich focal adhesions, whereas type F cells are highly motile and exert integrin-dependent bone marrow homing capacity in nonobese diabetic/severe combined immunodeficient mice. Flow cytometry indicated that type A cells express significantly higher levels of CD45 and CD56 and lower levels of CD138 compared with type F cells. Interestingly, culturing of either type A or type F cells under nonselective conditions resulted in the development of mixed cell population similar to the parental ARH-77 cells. Analysis of bone marrow aspirates of multiple myeloma patients revealed that spicules within the aspirates are enriched with type A-like cells. Nonadherent cells within the aspirate fluids express a marker profile similar to type F cells. This study indicates that multiple myeloma patients contain heterogeneous populations of malignant plasma cells that display distinct properties. Diverse subpopulations of malignant plasma cells may play distinct roles in the different biological and clinical manifestations of plasma cell dyscrasias, including bone dissemination and selective adhesion to bone marrow compartments.
Nadav
Liat
L
The Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel.
Katz
Ben-Zion
BZ
Baron
Shoshana
S
Cohen
Nir
N
Naparstek
Elizabeth
E
Geiger
Benjamin
B
D002448:Cell Adhesion; D002460:Cell Line; D045744:Cell Line, Tumor; D002471:Cell Transformation, Neoplastic; D014644:Genetic Variation; D006801:Humans; D016023:Integrins / Q000276:immunology / Q000502:physiology; D007938:Leukemia / Q000235:genetics / Q000503:physiopathology; D009101:Multiple Myeloma / Q000235:genetics* / Q000503:physiopathology; D051419:Paxillin / Q000502:physiology; D010950:Plasma Cells / Q000502:physiology*; D018911:Trinucleotide Repeats
D016023:Integrins; D051419:Paxillin